L3VLUP
ProSign in

ELDN in the 13F filings

Eledon Pharmaceuticals Inc · CUSIP 28617K101

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q1 2023Q2 2022Q1 2022Q4 2021Q3 2021
Quarter end
31 Mar 2022
the date the book describes
Filed
16 May 2022
up to 45 days after the quarter end
Managers listing it
1
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q4 2021 and Q1 2022; 1 listed it in both
Shares listed
673,138
combined, among listed positions
Reported value
$2.7m
combined, at the quarter end

Managers listing ELDN in Q1 2022

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q4 2021, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

1 of 1 holder

ActionFiling
Woodline Partners LP673,138$2.7munder 0.1%Trimmed-108,23816 May 2022 (the filing on sec.gov)

Largest increases and reductions, by shares

Q4 2021 to Q1 2022, among managers that listed it in both quarters or opened it.

Increases

No increase among listed positions.

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
1 in Q1 2023 to 1 in Q1 2025

Tracked managers listing it, at least.

01122Q1 2021Q3 2021Q1 2022Q1 2023Q4 2023Q2 2024Q4 2024Q1 2025
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
ELDN by quarter
QuarterHoldersReported valueBuyersSellers
Q1 20211$9.5mn.a.n.a.
Q2 20211$6.8mn.a.n.a.
Q3 20211$4.8mn.a.n.a.
Q4 20211$3.4mn.a.n.a.
Q1 20221$2.7mn.a.n.a.
Q2 20221$1.3mn.a.n.a.
Q1 20231$1.2mn.a.n.a.
Q3 20231$827kn.a.n.a.
Q4 20231$1.2m10
Q1 20241$1.3m01
Q2 20241$1.8m10
Q3 20241$2.1m10
Q4 20242$13m20
Q1 20251$5.7m00

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

ELDN and LLY →ELDN and JNJ →ELDN and VRTX →Choose a stock to compare with ELDN →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own ELDN, latest filings →Back to the 13F Explorer →